Atlas Trials

Neo-adjuvant Abiraterone + Luteinizing Hormone-Releasing Hormone (LHRH) Versus LHRH in Prostate Cancer

Clinical trial NCT01088529 · COMPLETED

Trial details

NCT number
NCT01088529
Sponsor
Cougar Biotechnology, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2009-12-01
Primary completion
2013-03-01
Enrollment
66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.